|
SUPPLEMENTAL FINANCIAL INFORMATION
STOCK-BASED COMPENSATION EXPENSE (Unaudited, in thousands) | |||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, | ||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| Cost of revenue | $ | 1,186 | $ | 922 | $ | 3,691 | $ | 2,622 | |||||||
| Research and development | 9,287 | 6,646 | 26,875 | 19,564 | |||||||||||
| Selling, general and administrative | 32,524 | 24,004 | 95,157 | 70,096 | |||||||||||
| Total stock-based compensation expense | $ | 42,997 | $ | 31,572 | $ | 125,723 | $ | 92,282 | |||||||
|
RECONCILIATION OF NET INCOME TO NON-GAAP NET INCOME
(Unaudited, in thousands, except per share amounts) | ||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Net income | $ | 124,337 | $ | 68,770 | $ | 318,582 | $ | 169,352 | ||||||||
| Adjustments to reconcile net income to non-GAAP net income: | ||||||||||||||||
| Stock-based compensation expense | 42,997 | 31,572 | 125,723 | 92,282 | ||||||||||||
| Amortization of purchased intangible assets | 33 | 11 | 99 | 11 | ||||||||||||
| Deferred compensation plan expense (income) | 125 | 76 | (350 | ) | 309 | |||||||||||
| Tax effect | 3,161 | (1,804 | ) | 1,885 | (7,382 | ) | ||||||||||
| Non-GAAP net income | $ | 170,653 | $ | 98,625 | $ | 445,939 | $ | 254,572 | ||||||||
| Non-GAAP net income per share: | ||||||||||||||||
| Basic | $ | 3.64 | $ | 2.15 | $ | 9.56 | $ | 5.56 | ||||||||
| Diluted | $ | 3.53 | $ | 2.06 | $ | 9.23 | $ | 5.33 | ||||||||
| Shares used in the calculation of non-GAAP net income per share: | ||||||||||||||||
| Basic | 46,829 | 45,970 | 46,643 | 45,754 | ||||||||||||
| Diluted | 48,349 | 47,852 | 48,295 | 47,772 | ||||||||||||
